InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the ” Alopecia Market – (By Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Androgenetic Alopecia, Alopecia Totalis, Alopecia Universalis), By Treatment (Pharmaceutical, Devices), By Gender (Male, Female), By Sales Channel (Prescriptions, OTC), By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”
According to the latest research by InsightAce Analytic, the Alopecia Market is valued at US$ 8.6 billion in 2023, and it is expected to reach US$ 17.8 billion by 2031, with a CAGR of 9.8% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2892
Alopecia is an autoimmune condition in which the body’s immune system targets hair follicles, leading to varying degrees of hair loss. The global market for alopecia treatments includes a diverse portfolio of therapeutic products and medical interventions designed to manage this disorder. The market is expected to experience substantial growth in the coming years, driven primarily by the rising prevalence of chronic conditions associated with hair loss and ongoing advancements in treatment technologies.
Increased public awareness of alopecia, coupled with the availability of effective therapeutic solutions and higher disposable incomes, is projected to create significant revenue opportunities for industry players.
Additionally, robust investments from leading stakeholders and continuous innovation in the development of treatment modalities are enhancing growth prospects for manufacturers and service providers. Government initiatives aimed at mitigating the impact of hair loss are also anticipated to support market expansion and strengthen overall industry growth throughout the forecast period.
List of Prominent Players in the Alopecia Market:
- Janssen Global Services Inc.
- Cipla Limited
- Merck & Co., Inc.
- GlaxoSmithKline Plc
- Sun Pharmaceuticals Industries Ltd
- Dr Reddy’s Laboratories Ltd
- Aurobindo Pharma
- Viatris Inc.
- Pfizer, Inc.
- Eli Lilly
- Lexington Intl., LLC
- Freedom Laser Therapy
- Curallux, LLC
- Apira Sciences Inc.
- Revian Inc.
- Theradome
- Lutronic
- iRestore Hair Growth System
- iGrow Laser
- Theradome
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Market Dynamics
Growth Drivers:
The global alopecia market is poised for substantial growth, underpinned by several key factors. An expanding geriatric population, rising incidence of chronic conditions linked to hair loss, and heightened consumer awareness regarding available treatment options are expected to drive demand.
The increasing adoption of advanced therapeutic technologies is anticipated to contribute significantly to market revenue. In addition, continuous innovation in treatment solutions, supported by favorable government initiatives, is likely to accelerate market expansion over the forecast period.
Challenges:
Despite promising market potential, several challenges persist. Limited awareness of potential side effects associated with hair loss treatments—particularly in emerging regions—may constrain market penetration. Furthermore, the high cost of advanced alopecia therapies represents a significant barrier to widespread adoption. The COVID-19 pandemic also disrupted the market, creating supply chain constraints, reducing retail activity, and causing temporary production stoppages for manufacturers.
Regional Insights:
North America is expected to maintain its position as the leading regional market for alopecia, driven by a growing elderly population, increasing prevalence of hair loss-related conditions, and robust research and development initiatives undertaken by major industry stakeholders.
The region is projected to sustain a strong compound annual growth rate (CAGR) throughout the forecast period. Meanwhile, the Asia-Pacific region is anticipated to exhibit notable growth, supported by rapid economic development and the strategic deployment of innovative technologies and business models by key players in the alopecia sector.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2892
Recent Developments:
- In July 2024, Sun Pharmaceutical Industries Ltd has announced that its LEQSELVI (deuruxolitinib) drug has been approved by the US health regulatory agency to treat severe alopecia areata in adults. Sun Pharma disclosed in a regulatory filing that the USFDA has granted approval for LEQSELVI (deuruxolitinib) 8 mg tablets.
- In July 2023, REVIAN Inc. released that the Revian Red Hair Growth System is anticipated to be in the second study. It is projected as an effective treatment option for Central Centrifugal Cicatricial Alopecia.
Segmentation of Alopecia Market-
By Disease Type-
- Alopecia Areata
- Cicatricial Alopecia
- Traction Alopecia
- Alopecia Totalis
- Alopecia Universalis
- Androgenetic Alopecia
- Others
By Treatment-
- Pharmaceuticals
- Topical
- OTC
- Minoxidil
- Others
- Prescription
- Betamethasone Dipropionate
- Fluocinolone Acetonide
- Finasteride
- Minoxidil
- Oral
- OTC
- Prescription
- Minoxidil
- Finasteride
- Corticosteroids
- Others (JAK inhibitors and others)
- PRP
- OTC
- Devices
- Laser Cap
- Laser Comb
- Laser Helmet
- OTC
- Topical
By Gender-
- Male
- Female
By Sales Channel-
- Prescriptions
- OTC
By End Use-
- Homecare Settings
- Dermatology Clinics
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
